Ocular Therapeutix, Inc. (OCUL)
11.12
-0.30
(-2.67%)
USD |
NASDAQ |
Jan 22, 16:00
11.21
+0.10
(+0.85%)
After-Hours: 20:00
Ocular Therapeutix Shareholders Equity (Quarterly): 258.23M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp. | 23.39B |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Dynavax Technologies Corp. | 534.14M |
| Vertex Pharmaceuticals, Inc. | 17.32B |
| Krystal Biotech, Inc. | 1.138B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 410.88M |
| Total Liabilities (Quarterly) | 152.65M |
| Debt to Equity Ratio | 0.2982 |
| Current Ratio | 7.850 |
| Net Debt Paydown Yield | -0.02% |